Market Tracker

02/20 7:53am ET

ImmuCell Corp (NASDAQ:ICCC)

5.52
Delayed Data
As of Feb 17
 -0.20 / -3.50%
Today’s Change
4.76
Today|||52-Week Range
8.24
-7.23%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close5.72
Today’s open5.60
Day’s range5.52 - 5.83
Volume3,406
Average volume (3 months)12,467
Market cap$26.8M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-68.42%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.69%
P/E ratio27.6
Price/Sales2.70
Price/Book1.36

Competitors

 Today’s
change
Today’s
% change
WGBSWaferGen Bio-systems...+0.14+2.08%
PTIEPain Therapeutics In...+0.01+1.95%
HSGXHistogenics Corp+0.01+0.58%
DRIODarioHealth Corp+0.13+3.49%
Data as of 4:00pm ET, 02/17/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$9.5M
Annual profit (last year)$508.0K
Net profit margin5.32%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts